We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
From May 2021 to May 2024
By Joe Hoppe
Unilever PLC said Wednesday that it won't increase its 50 billion-pound ($67.98 billion) offer for GlaxoSmithKline PLC's majority-owned consumer healthcare division, after noting its financial assumptions and determining it doesn't change its fundamental value view.
The U.K.-based consumer-goods group said it is committed to maintaining strict financial discipline in order to ensure its acquisitions create value for its shareholders.
"Unilever also reiterates its commitment to continuing to improve the performance of its existing portfolio through its ongoing focus on operational excellence, its upcoming reorganization and by rotating the portfolio to higher growth categories," the company said.
Unilever said on Saturday that it had made an approach to Glaxo and Pfizer Inc. Glaxo had set out plans to spin off the division, but also said it would potentially be open to a sale. The unit, which is 68% owned by Glaxo and 32% by Pfizer, sells products ranging from Aquafresh toothpaste to Advil painkillers.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
January 19, 2022 12:00 ET (17:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
